Concepedia

Donn Young

DY

Statistics

Publications

6

Citations

555

H-Index

6

Active since

1984

Affiliations

The Ohio State University(Current)

Donn Young is an author at The Ohio State University specializing in medicine, oncology, and cancer pharmacology.

Publications per year

1984–2010

6

Publications

6

Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors

Manisha H. Shah, Philip F. Binkley, Kenneth K. Chan et al. · Clinical Cancer Research · 2006 · 243 citations

, , +17

Phase II Study of the Proteasome Inhibitor Bortezomib (PS-341) in Patients with Metastatic Neuroendocrine Tumors

Manisha H. Shah, Donn Young, Hedy L. Kindler et al. · Clinical Cancer Research · 2004 · 132 citations · Full text

, , +17

Interferon-alpha therapy of renal cancer.

James A. Neidhart, Mary M. Gagen, Donn Young et al. · PubMed · 1984 · 81 citations

, , +15

Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.

John J. Rinehart, Louis Malspeis, Donn Young et al. · PubMed · 1986 · 52 citations

, , +10

Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.

John J. Rinehart, Donn Young, Julie LaForge et al. · PubMed · 1987 · 31 citations

, , +17

1–5 of 6